BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/2/2023 8:18:01 AM | Browse: 39 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 84966
Country China
Category Gastroenterology & Hepatology
Manuscript Type Clinical Trials Study
Article Title Raf kinase inhibitor protein combined with phosphorylated extracellular signal-regulated kinase offers valuable prognosis in gastrointestinal stromal tumor
Manuscript Source Unsolicited Manuscript
All Author List Wen-Zhi Qu, Luan Wang, Juan-Juan Chen and Yang Wang
Funding Agency and Grant Number
Funding Agency Grant Number
Natural Science Foundation of Liaoning Province 2020-MS-148
Corresponding Author Yang Wang, MD, PhD, Associate Professor, Doctor, Department of General Surgery, The 4th Affiliated Hospital of China Medical University, No.4 Chongshan Road, Huanggu District, Shenyang 110032, Liaoning Province, China. wwyy840731@126.com
Key Words Raf kinase inhibitory protein; Phosphorylated extracellular-signal-regulated kinase; Gastrointestinal stromal tumors; Immunohistochemistry; Survival analysis; Risk grade model
Core Tip Nowadays, research reports on the expression of downstream proteins of the Extracellular Signal-Regulated Kinase (ERK)/Mitogen-activated protein kinase pathway combined with Raf Kinase Inhibitor Protein (RKIP) in gastrointestinal stromal tumor (GIST) is scarce. This study will focus on this aspect and use immunohistochemistry methods, large sample survival analysis data, and the latest bioinformatics analysis techniques to answer the problem. Our experimental results showed that the expression of the two proteins had a certain negative correlation. The combined expression of RKIP and p-ERK proteins can serve as an independent risk factor for predicting the prognosis of GIST patients. Furthermore, the new risk assessment model incorporating RKIP and p-ERK has superior evaluation efficacy.
Citation Qu WZ, Wang L, Chen JJ, Wang Y. Raf kinase inhibitor protein combined with phosphorylated extracellular signal-regulated kinase offers valuable prognosis in gastrointestinal stromal tumor. World J Gastroenterol 2023; 29(26): 4200-4213
Received
2023-04-24 08:00
Peer-Review Started
2023-04-24 08:00
To Make the First Decision
Return for Revision
2023-05-16 02:33
Revised
2023-05-20 03:17
Second Decision
2023-06-02 03:11
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2023-06-02 08:18
Articles in Press
2023-06-02 08:18
Publication Fee Transferred
Edit the Manuscript by Language Editor
2023-06-10 20:16
Typeset the Manuscript
2023-06-24 07:04
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com